Newsweek – Gilead Sciences Inc. said it is recalling tens of thousands of vials of its COVID-19 drug treatment remdesivir due to glass contamination, which it warned could lead to adverse health effects such as stroke or even death. The company said Friday that it would carry out a voluntary recall of two lots of … Continue reading Gilead recalling 55,000 of vials of its COVID-19 drug treatment remdesivir due to glass contamination